LUMICKS is the world-leader in Dynamic Single-Molecule analysis (“DSM”) and is focused on establishing this breakthrough approach as a standard analytical method in molecular biology and drug discovery. We achieve this through the increasingly rapid adoption by scientific KOLs and publications by early adopters, as well as through our growing pharma customer base. With a complementary and growing product line, LUMICKS is well-positioned to capitalize on the market opportunity for this technology across the academic and pharma segments.
Akron Biotech drives advanced therapy development and commercialization with high quality, industrial scale solutions. Akron’s strategic focus is supplying GMP-compliant ancillary materials and services to enable the advancement of cell and gene therapies. These include cytokines and growth factors, human sera and purified proteins, cryopreservation solutions, and custom development services. An ISO 13485-certified company operating in line with cGMP guidelines and international standards, Akron provides advanced therapy developers the scale, compliance, and regulatory support to develop novel treatments.